参考文献/References:
[1] Robinson RG,Bloom FE.Pharmacological treatment following experimental cerebral infarction:implications for understanding psychological symptoms of human stroke[J].Biol Psychiatry,1977,12(5):669-680.
[2] Gao HQ,Zhu HY,Zhang YQ,et al.Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression:A preliminary report[J].Clinical and Investigative Medicine,2008,31(6):E351-E356.
[3] Wang SH,Zhang ZJ,Guo YJ,et al.Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress:a rat model of post-stroke depression[J].Psychiatry Res,2009,170(2/3):245-251.
[4] Ji XW,Wu CL,Wang XC,et al.Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression[J].Exp Ther Med,2014,8(1):159-164.
[5] Karaiskos D,Tzavellas E,Spengos K,et al.Duloxetine versus citalopram and sertraline in the treatment of poststroke depression,anxiety,and fatigue[J].J Neuropsychiatry Clin Neurosci,2012,24(3):349-353.
[6] Kraglund KL,Mortensen JK,Grove EL,et al.TALOS:a multicenter,randomized,double-blind,placebo-controlled trial to test the effects of citalopram in patients with acute stroke[J].Int J Stroke,2015,10(6):985-987.
[7] Niciu MJ,Kelmendi B,Sanacora G.Overview of glutamatergic neurotransmission in the nervous system[J].Pharmacol Biochem Behav,2012,100(4):656-664.
[8] Valentine GW,Sanacora G.Targeting glial physiology and glutamate cycling in the treatment of depression[J].Biochem Pharmacol,2009,78(5):431-439.
[9] Niciu MJ,Kelmendi B,Sanacora G.Overview of glutamatergic neurotransmission in the nervous system[J].Pharmacol Biochem Behav,2012,100(4):656-664.
[10] Wang X,Li YH,Li MH,et al.Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression[J].Eur Arch Psychiatry Clin Neurosci,2012,262(1):33-38.
[11] Park M,Niciu MJ,Zarate CA.Novel glutamatergic treatments for severe mood disorders[J].Current behavioral neuroscience reports,2015,2(4):198-208.
[12] Costi S,Van Dam NT,Murrough JW.Current status of ketamine and related therapies for mood and anxiety disorders[J].Current behavioral neuroscience reports,2015,2(4):216-225.
[13] Müller N,Myint AM,Schwarz MJ.Inflammatory biomarkers and depression[J].Neurotox Res,2011,19(2):308-318.
[14] Pascoe MC,Crewther SG,Carey LM,et al.Inflammation and depression:why poststroke depression May be the norm and not the exception[J].Int J Stroke,2011,6(2):128-135.
[15] Su JA,Chou SY,Tsai CS,et al.Cytokine changes in the pathophysiology of post-stroke depression[J].Gen Hosp Psychiatry,2012,34(1):35-39.
[16] Miller AH.Norman cousins lecture.mechanisms of cytokine-induced behavioral changes:psychoneuroimmunology at the translational interface[J].Brain Behav Immun,2009,23(2):149-158.
[17] Zhu CB,Blakely RD,Hewlett WA.The proinflammatory cytokines interleukin-1beta and tumor necrosis factoralpha activate serotonin transporters[J].Neuropsychopharmacology,2006,31(10):2121-2131.
[18] Spalletta G,Bossù P,Ciaramella A,et al.The etiology of poststroke depression:a review of the literature and a new hypothesis involving inflammatory cytokines[J].Mol Psychiatry,2006,11(11):984-991.
[19] Feng C,Fang M,Liu XY.The neurobiological pathogenesis of poststroke depression[J].ScientificWorldJournal,2014(2014):521349.
[20] Fan T,Jiang WL,Zhu J,et al.Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation[J].Biol Pharm Bull,2012,35(11):2004-2009.
[21] Wang S,Yuan Y,Xia W,et al.Neuronal apoptosis and synaptic density in the dentate gyrus of ischemic rats' response to chronic mild stress and the effects of Notch signaling[J].PLoS One,2012,7(8):e42828.
[22] Kubera M,Obuchowicz E,Goehler L,et al.In animal models,psychosocial stress-induced(neuro)inflammation,apoptosis and reduced neurogenesis are associated to the onset of depression[J].Prog Neuropsychopharmacol Biol Psychiatry,2011,35(3):744-759.
[23] Lucassen PJ,Fuchs E,Czéh B.Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex[J].Biol Psychiatry,2004,55(8):789-796.
[24] Maes M.The cytokine hypothesis of depression:inflammation,oxidative & nitrosative stress(IO&NS)and leaky gut as new targets for adjunctive treatments in depression[J].Neuro Endocrinol Lett,2008,29(3):287-291.
[25] Carvalho LA,Pariante CM.In vitro modulation of the glucocorticoid receptor by antidepressants[J].Stress,2008,11(6):411-424.
[26] Pace TW,Hu F,Miller AH.Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha[J].Brain Behav Immun,2011,25(8):1716-1724.
[27] Reimold M,Knobel A,Rapp MA,et al.Central serotonin transporter levels are associated with stress hormone response and anxiety[J].Psychopharmacology(Berl),2011,213(2/3):563-572.
[28] Robinson RG,Kubos KL,Starr LB,et al.Mood changes in stroke patients:relationship to lesion location[J].Compr Psychiatry,1984,24(6):555-566.
[29] Rajashekaran P,Pai K,Thunga R,et al.Post-stroke depression and lesion location:A hospital based cross-sectional study[J].Indian J Psychiatry,2013,55(4):343-348.
[30] Jiang XG,Lin Y,Li YS.Correlative study on risk factors of depression among acute stroke patients[J].Eur Rev Med Pharmacol Sci,2014,18(9):1315-1323.
[31] Tang WK,Lu JY,Chen YK,et al.Association of frontal subcortical circuits infarcts in poststroke depression:a magnetic resonance imaging study of 591 Chinese patients with ischemic stroke[J].J Geriatr Psychiatry Neurol,2011,24(1):44-49.
[32] Terroni L,Amaro E,Iosifescu DV,et al.Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode:a 4-month prospective study[J].World J Biol Psychiatry,2011,12(7):539-548.
[33] Shi YZ,Xiang YT,Wu SL,et al.The relationship between frontal lobe lesions,course of post-stroke depression,and 1-year prognosis in patients with first-ever ischemic stroke[J].PLoS One,2014,9(7):e100456.
[34] Wichowicz HM,Gsecki D,Landowski J,et al.Clinical utility of chosen factors in predicting post-stroke depression:a one year follow-up[J].Psychiatr Pol,2015,49(4):683-696.
[35] Bhogal SK,Teasell R,Foley N,et al.Lesion location and poststroke depression:systematic review of the methodological limitations in the literature[J].Stroke,2004,35(3):794-802.
[36] Wei N,Yong W,Li X,et al.Post-stroke depression and lesion location:a systematic review[J].J Neurol,2015,262(1):81-90.
[37] Starr LR,Hammen C,Brennan PA,et al.Serotonin transporter gene as a predictor of stress Generation in depression[J].J Abnorm Psychol,2012,121(4):810-818.
[38] Guo WY,Zhang ZH,Mu JL,et al.Relationship between 5-HTTLPR polymorphism and post-stroke depression[J].Genet Mol Res,2016,15(1):doi:10.4238/gmr.15017460.
[39] Mak KK,Kong WY,Mak A,et al.Polymorphisms of the serotonin transporter gene and post-stroke depression:a meta-analysis[J].J Neurol Neurosurg Psychiatry,2013,84(3):322-328.
[40] Fang J,Yan W,Jiang GX,et al.Serotonin transporter gene polymorphism in Chinese patients with poststroke depression:a case-control study[J].Stroke,2011,42(5):1461-1463.
[41] Eisch AJ,Petrik D.Depression and hippocampal neurogenesis:a road to remission?[J].Science,2012,338(613):72-75.
[42] Chen HH,Zhang N,Li WY,et al.Overexpression of brain-derived neurotrophic factor in the hippocampus protects against post-stroke depression[J].Neural Regeneration Research,2015,10(9):1427-1432.
[43] Kim JM,Stewart R,Kim SW,et al.BDNF genotype potentially modifying the association between incident stroke and depression[J].Neurobiol Aging,2008,29(5):789-792.
[44] Lewin A,J bges M,Werheid K.The influence of self-efficacy,pre-stroke depression and perceived social support on self-reported depressive symptoms during stroke rehabilitation[J].Neuropsychol Rehabil,2013,23(4):546-562.